Literature DB >> 29947880

Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? Yes.

Anders Perner1, Simon Finfer2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29947880     DOI： 10.1007/s00134-018-5129-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  Adaptive clinical trials: a partial remedy for the therapeutic misconception?

Authors:  William J Meurer; Roger J Lewis; Donald A Berry
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

3.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

4.  The platform trial: an efficient strategy for evaluating multiple treatments.

Authors:  Scott M Berry; Jason T Connor; Roger J Lewis
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

Review 5.  Interventions affecting mortality in critically ill and perioperative patients: A systematic review of contemporary trials.

Authors:  Martina Baiardo Redaelli; Giovanni Landoni; Stefania Di Sanzo; Samuele Frassoni; Chiara Sartini; Luca Cabrini; Giacomo Monti; Mara Scandroglio; Alberto Zangrillo; Rinaldo Bellomo
Journal:  J Crit Care       Date:  2017-05-04       Impact factor: 3.425

6.  Lower versus higher hemoglobin threshold for transfusion in septic shock.

Authors:  Lars B Holst; Nicolai Haase; Jørn Wetterslev; Jan Wernerman; Anne B Guttormsen; Sari Karlsson; Pär I Johansson; Anders Aneman; Marianne L Vang; Robert Winding; Lars Nebrich; Helle L Nibro; Bodil S Rasmussen; Johnny R M Lauridsen; Jane S Nielsen; Anders Oldner; Ville Pettilä; Maria B Cronhjort; Lasse H Andersen; Ulf G Pedersen; Nanna Reiter; Jørgen Wiis; Jonathan O White; Lene Russell; Klaus J Thornberg; Peter B Hjortrup; Rasmus G Müller; Morten H Møller; Morten Steensen; Inga Tjäder; Kristina Kilsand; Suzanne Odeberg-Wernerman; Brit Sjøbø; Helle Bundgaard; Maria A Thyø; David Lodahl; Rikke Mærkedahl; Carsten Albeck; Dorte Illum; Mary Kruse; Per Winkel; Anders Perner
Journal:  N Engl J Med       Date:  2014-10-01       Impact factor: 91.245

7.  Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults.

Authors:  D James Cooper; Zoe K McQuilten; Alistair Nichol; Bridget Ady; Cécile Aubron; Michael Bailey; Rinaldo Bellomo; Dashiell Gantner; David O Irving; Kirsi-Maija Kaukonen; Colin McArthur; Lynne Murray; Ville Pettilä; Craig French
Journal:  N Engl J Med       Date:  2017-09-27       Impact factor: 91.245

8.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

Review 9.  The design of randomized clinical trials in critically ill patients.

Authors:  Paul C Hébert; Deborah J Cook; George Wells; John Marshall
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

Review 10.  A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.

Authors:  D C Angus; A E Barnato; D Bell; R Bellomo; C-R Chong; T J Coats; A Davies; A Delaney; D A Harrison; A Holdgate; B Howe; D T Huang; T Iwashyna; J A Kellum; S L Peake; F Pike; M C Reade; K M Rowan; M Singer; S A R Webb; L A Weissfeld; D M Yealy; J D Young
Journal:  Intensive Care Med       Date:  2015-05-08       Impact factor: 17.440
View more
  1 in total

1.  Identifying and characterizing high-risk clusters in a heterogeneous ICU population with deep embedded clustering.

Authors:  José Castela Forte; Galiya Yeshmagambetova; Maureen L van der Grinten; Bart Hiemstra; Thomas Kaufmann; Ruben J Eck; Frederik Keus; Anne H Epema; Marco A Wiering; Iwan C C van der Horst
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.